IL23A, Human (Risankizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-IL23A, Human (Risankizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityIL23A, Human (Risankizumab biosimilar)
CloneRisankizumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human IL23A Recombinant Antibody (Risankizumab). Risankizumab, sold under the brand name Skyrizi, is a humanized monoclonal antibody targeting interleukin 23A (IL-23A). Risankizumab is part of a collaboration between Boehringer Ingelheim and AbbVie.
Immunogenn/a
Other NamesAnti-IL23A Recombinant Antibody, Research Grade Risankizumab, Anti-Human IL23A Recombinant Antibody(Risankizumab), BI 655066, risankizumab-rzaa, Antibody Drug Analogues, Monoclonal Antibody, YR1385, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1612838-76-2
Catalog #YR1385
Priceplease inquire
Order / More InfoIL23A, Human (Risankizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.